You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》傳諾誠健華下周舉行投資者視像會議 集資2-3億美元
阿思達克 02-26 09:31
據《彭博》引述知情人士報道,早前因新型肺炎疫情而延遲招股計劃的未盈利生物科技公司諾誠健華(Innocare Pharma),將在下周與投資者舉行視像會面,以評估市場需求,預料集資約2億至3億美元,由摩根士丹利及高盛擔任聯席保薦人。 諾誠健華於去年10月向聯交所申請上市,初步招股文件顯示,該公司已研發9種候選藥物,包括1種處於註冊性試驗的候選藥物、2種處於I/II期臨床試驗的候選藥物及6種處於IND準備階段的候選藥物,去年上半年虧損擴大逾15%至3.21億元人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account